Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-54.44	19.36	42.50
Graham Fair Price	53.15	129545.99	84588.76
PEG	-93.35	0.05	-0.82
Price/Book	-15.82	2.61	3.10
Price/Cash Flow	1150.36	565.89	45.26
Prices/Earnings	-56.23	6.11	13.96
Price/Sales	-21.26	4.21	5.35
Price/FCF	1150.36	565.89	45.26
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	7.77	0.42	0.39
Operating Margin	87.62	0.21	0.11
ROA	102.38	0.05	0.03
ROE	0.06	0.11	92.31
ROIC	0.03	0.07	128.36
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.08	-96.81
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.17	1.22	626.89
EPS QOQ	-0.17	1.12	557.85
FCF QOQ	-0.10	-0.93	-851.60
Revenue QOQ	-0.03	0.18	612.11
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	63.91	49.68	-22.26
Days Sales Outstanding (DSO)	25.60	25.88	1.08
Inventory Turnover	1.41	1.81	28.64
Debt/Capitalization	0.36	0.33	-6.47
Quick Ratio	0.83	0.85	1.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	75732.33	83636.46	10.44
Cash	32318.31	32375.37	0.18
Capex	-2295.59	-9401.04	-309.53
Free Cash Flow	5181.40	385.24	-92.57
Revenue	43810.64	51721.93	18.06
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.22	1.18	-3.64
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.79	1.38	-50.67
Naive Interpretation	Member

06 - Financial Health · Bad

Rating